Senior Global Group Head Biometrics and Statistical Science , Basel Area, Switzerland

The Senior Global Group Head Biometrics and Statistical Science is an influential leader with a strong understanding of the drug development process, therapeutic knowledge and experience, substantial experience in scientific and regulatory activities, with well-established track record for strong scientific and organizational leadership. The successful candidate will:

1. Lead and oversee – all aspects of quantitative statistical disciplines – all development programs within a complex CSU or Disease area and/or cross CSU activities in multiple disease areas, with a predominant focus on drug development decision making supporting and driving drug development milestone transitions, regulatory approvable dossiers, and there defense globally, market access, commercialization and life-cycle management of products. Provides strategic leadership to the design and development of R&D plans comprising, regulatory, and scientific strategies, impact decisions at management level (CSU, disease area or translational medicine).

2. Provide organizational leadership by managing and developing a complex CSU or Disease area and/or cross CSU /disease area focused global group of 10-40 (Direct and indirect) associates comprised of biometricians and statistical scientist up to and including associates at the Executive director level.

3. Influence the external environment as a thought leader and are a key contributor to strategic long-term decision-making by Novartis Senior Management, and work with Senior leadership to drive portfolio level investments and decision making

4. Provide CSU or disease area level scientific input and strategic influence into drug development design and quantitative decision making, in collaboration with medi-cal/translation medicine leadership.

5. Be accountable for strategic statistical input into the CSU or disease are through leadership of a team of Biometricians and Statistical Scientists. Establish relationships with clinical and regulatory drug development partners to enable successful impact on clinical development strategies and drive Quantitative drug development decision making, with a focus on large/high priority program/brand or for multiple complex programs (e.g. multiple indications, concurrent global submissions, large scale program of studies).

3. Perform the role of a Chief Counsel to IIS Global Franchise Head and Chief Statistical Officer on program stra-tegic issues; responsible to drive innovation in execution of biometrics and statistical sciences team and partner with IIS Global Franchise Head, Operations to insure high quality IIS integrated cross-functional delivery.

4. Be a member of the Franchise global statistics leadership team. Ensure development of franchise organization as an industry leading biometrics and statistical science or-ganization, engaged internally and externally to influence pharmaceutical statistics practice. Drive high quality objective Health Authority interactions and external relations.

5. Drive collaboration with key internal quantitative partners (M&S,DS&E, Stat Methods etc.) to optimize development strategies for compounds and entire disease areas

Desired Skills & Experience

PhD in Biostatistics (or equivalent)

15+ years industry experience

5+ years multi / cross functional international leadership experience

Advanced understanding of the drug development process and programs with significant experience in scientific Regulatory activities.

Established track record for strong scientific and organizational leadership.

In-depth Therapeutic knowledge and strong connections in the external environment in this therapeutic area, and proven record of influencing the external environment.

Substantial track record in identifying and leading contribution to external white-papers/policy shaping best practice statistical science

Proven record for providing thought-leading insights to the competitive environment and internal partner interfaces

Proven people leadership capabilities

Model natural leadership characteristics in harnessing and managing a diverse business

Expert skills to facilitate/optimize contribution of team members as individuals and members of cohesive team

Excellent interpersonal and communication skills, able to naturally bridge scientific and business participants; Track record in enabling effective international collaboration

Outstanding verbal and written communications

Proven track record in working across a matrix organization and demonstrates expert skills in building partnerships, negotiating agreements

Expert skills in leveraging and maximizing the contribution of diverse team members as both single contributors and as cohesive, efficient teams

Drug development expert in R&D encompassing; strategy, science, planning, execution, reporting, regulatory review, submission and commercialization

Languages: Excellent English required (oral & written)

Company Description

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2011, the Group achieved net sales of USD 58.6 billion, while approximately USD 9.6 billion (USD 9.2 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 127,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.